ATEC:NSD-Alphatec Holdings Inc (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 9.23

Change

+0.11 (+1.21)%

Market Cap

USD 1.37B

Volume

0.50M

Analyst Target

USD 9.80
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

+0.70 (+0.88%)

USD 30.74B
PODD Insulet Corporation

-0.10 (-0.04%)

USD 19.01B
MASI Masimo Corporation

+0.80 (+0.48%)

USD 9.43B
BRKR Bruker Corporation

+0.86 (+1.50%)

USD 9.04B
PRCT Procept Biorobotics Corp

+2.57 (+3.17%)

USD 4.83B
NVCR Novocure Ltd

+0.48 (+1.57%)

USD 3.61B
NARI Inari Medical Inc

+0.41 (+0.77%)

USD 3.25B
LIVN LivaNova PLC

-0.24 (-0.51%)

USD 2.83B
IRTC iRhythm Technologies Inc

+0.71 (+0.80%)

USD 2.67B
QDEL Quidel Corporation

-0.08 (-0.18%)

USD 2.57B

ETFs Containing ATEC

JFWD Jacob Forward ETF 4.71 % 0.00 %

N/A

USD 2.38M
XHE SPDR® S&P Health Care Eq.. 2.58 % 0.35 %

+0.55 (+0.00%)

USD 0.21B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -38.91% 41% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.91% 41% F 22% F
Trailing 12 Months  
Capital Gain -39.83% 39% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -39.83% 39% F 22% F
Trailing 5 Years  
Capital Gain 26.96% 85% B 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.96% 85% B 62% D
Average Annual (5 Year Horizon)  
Capital Gain 63.81% 81% B- 89% A-
Dividend Return 63.81% 81% B- 89% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 162.76% 24% F 15% F
Risk Adjusted Return 39.21% 89% A- 70% C-
Market Capitalization 1.37B 84% B 74% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector